| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Huntington's Disease
|
NIAAA
|
1K22AA016991-01
|
|
Ethanol Effects on Neostriatal Function
|
YIN, HENRY
|
DUKE UNIVERSITY
|
NC
|
$150,508
|
|
Huntington's Disease
|
NIMH
|
2R37MH049428-16A1
|
|
Genetic Regulation of Telencephalon Development
|
RUBENSTEIN, JOHN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$566,251
|
|
Huntington's Disease
|
NIGMS
|
5R01GM038219-20
|
|
Instability of Triplet Repeats in Mammalian Cells
|
WILSON, JOHN
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$308,050
|
|
Huntington's Disease
|
NIMH
|
5K02MH001527-10
|
|
Structural and Functional Analyses of Neuronal PTPs
|
LOMBROSO, PAUL
|
YALE UNIVERSITY
|
CT
|
$127,332
|
|
Huntington's Disease
|
NIGMS
|
5R01GM049076-13
|
|
Chemical Models of Protein beta-Sheet Interactions
|
NOWICK, JAMES
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$252,598
|
|
Huntington's Disease
|
NINDS
|
1R21NS056325-01A1
|
|
Small Molecules as Modulators of Polyglutamine Aggregation
|
BERTHELIER, VALERIE
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$197,761
|
|
Huntington's Disease
|
NINDS
|
5R01NS038712-09
|
|
Mechanisms of Polyglutamine Neurodegeneration
|
PAULSON, HENRY
|
UNIVERSITY OF IOWA
|
IA
|
$54,150
|
|
Huntington's Disease
|
NINDS
|
5R01NS047237-05
|
|
Modifiers of Huntingtin and Alpha-synuclein Toxicity
|
MUCHOWSKI, PAUL
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$378,893
|
|
Huntington's Disease
|
NINDS
|
5R01NS041669-07
|
|
Nuclear toxicity of Huntington disease protein
|
LI, XIAO-JIANG
|
EMORY UNIVERSITY
|
GA
|
$334,267
|
|
Huntington's Disease
|
NINDS
|
5R01NS050284-03
|
|
Regulation of Polyglutamine Aggregation and Toxicity
|
DIAMOND, MARC
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$344,914
|
|
Huntington's Disease
|
NINDS
|
5R01NS040738-08
|
|
Trafficking Defects in Huntingtons Disease
|
MCMURRAY, CYNTHIA
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$398,917
|
|
Huntington's Disease
|
NINDS
|
5R01NS053679-03
|
|
Mutant polyglutamine and neurotoxicity in Huntington's Disease
|
POIRIER, MICHELLE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$295,200
|
|
Huntington's Disease
|
NINDS
|
5F30NS048776-04
|
|
Ultrasensitive Detection in Clear and Turbid Media
|
TAHARI, ABDEL
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$16,875
|
|
Huntington's Disease
|
NINDS
|
5U01NS045806-05
|
|
Combination Drug Therapy in Huntington's Disease
|
FERRANTE, ROBERT
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$594,653
|
|
Huntington's Disease
|
NINDS
|
5R01NS045942-05
|
|
Molecular Regulation of a Striatal DARPP-32 Phenotype
|
EHRLICH, MICHELLE
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$334,491
|
|
Huntington's Disease
|
NIGMS
|
5R01GM063066-07
|
|
Fragility and Instability at Hairpin-Forming Trinucleotide Repeats in Yeast
|
FREUDENREICH, CATHERINE
|
TUFTS UNIVERSITY MEDFORD
|
MA
|
$309,001
|
|
Huntington's Disease
|
NINDS
|
5R01NS015841-30
|
|
Electroanalysis of Neurotransmitters and Modulators
|
WIGHTMAN, ROBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$284,076
|
|
Huntington's Disease
|
NINDS
|
5R01NS053912-03
|
|
Intrabodies as novel neurological therapeutics
|
MESSER, ANNE
|
WADSWORTH CENTER
|
NY
|
$317,687
|
|
Huntington's Disease
|
NINDS
|
5U01NS052592-03
|
|
Coenzyme Q10 in Huntington's Disease
|
CUDKOWICZ, MERIT
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$1,184,326
|
|
Huntington's Disease
|
NIMH
|
5R01MH060379-07
|
|
Ensemble Activity in Rat Striatum During Habit Learning
|
GRAYBIEL, ANN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$320,105
|
|
Huntington's Disease
|
NINDS
|
5R01NS039074-08
|
|
Mechanisms of Huntingtin Induced Neurodegeneration
|
FINKBEINER, STEVEN
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$378,893
|
|
Huntington's Disease
|
NINDS
|
5R01NS048588-03
|
|
rAAV-mediated knockdown for Huntington's disease
|
MANDEL, RONALD
|
UNIVERSITY OF FLORIDA
|
FL
|
$285,273
|
|
Huntington's Disease
|
NINDS
|
5R01NS054753-03
|
|
Elucidation of the structures and biological activities of huntingtin oligomers
|
MUCHOWSKI, PAUL
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$419,472
|
|
Huntington's Disease
|
NIA
|
5R01AG019206-07
|
|
Synaptic toxicity of Huntington disease protein
|
LI, XIAO-JIANG
|
EMORY UNIVERSITY
|
GA
|
$307,377
|
|
Huntington's Disease
|
NINDS
|
5R37NS037760-10
|
|
Neostriatal Cholinergic Interneurons Firing Patterns
|
WILSON, CHARLES
|
UNIVERSITY OF TEXAS SAN ANTONIO
|
TX
|
$309,142
|
|
Huntington's Disease
|
NIA
|
5F31AG026804-02
|
|
Proteasome function and age dependent Huntington's Disease (HD) pathology
|
TYDLACKA, SUZANNE
|
EMORY UNIVERSITY
|
GA
|
$28,402
|
|
Huntington's Disease
|
NINDS
|
5R01NS023868-21
|
|
Molecular Mechanisms of Axonal Transport
|
BRADY, SCOTT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$334,368
|
|
Huntington's Disease
|
NINDS
|
5K01NS055072-02
|
|
Identification of Novel Drugs against Huntington's Disease and Cerebral Ischemia
|
WANG, XIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$177,012
|
|
Huntington's Disease
|
NCI
|
2R01CA098730-05A1
|
|
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
|
ROSS, THEODORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$265,965
|
|
Huntington's Disease
|
NINDS
|
5R01NS036232-09
|
|
Neuronal function of huntingtin associated protein
|
LI, XIAO-JIANG
|
EMORY UNIVERSITY
|
GA
|
$334,688
|
|
Huntington's Disease
|
NIBIB
|
2R37EB003320-11
|
|
In vivo chemical monitoring using capillary separations
|
KENNEDY, ROBERT
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$334,756
|
|
Huntington's Disease
|
NINDS
|
1R01NS056224-01A2
|
|
Deranged calcium signaling and polyglutamine expansion disorders
|
BEZPROZVANNY, ILYA
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$343,438
|
|
Huntington's Disease
|
NINDS
|
5R01NS050352-04
|
|
MECHANISMS OF TRANSCRIPTIONAL REPRESSION IN HUNTINGTON'S DISEASE
|
KRAINC, DIMITRI
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$345,345
|
|
Huntington's Disease
|
NINDS
|
5R01NS051756-03
|
|
Identification of Novel Drugs that Counter Huntington's Disease
|
FRIEDLANDER, ROBERT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$356,928
|
|
Huntington's Disease
|
NIMH
|
5K23MH070554-03
|
|
Brain Imaging and Cognition in Huntington's Disease
|
READING, SARAH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$177,611
|
|
Huntington's Disease
|
NINDS
|
5R21NS057516-02
|
|
A Mouse Model of RNA-induced Neurotoxcity
|
MARGOLIS, RUSSELL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$215,250
|
|
Huntington's Disease
|
NINDS
|
5R01NS045016-05
|
|
Polyglutamine expansion and altered gene expression
|
LI, SHI-HUA
|
EMORY UNIVERSITY
|
GA
|
$234,835
|
|
Huntington's Disease
|
NINDS
|
2R01NS042613-06A1
|
|
Genetic Control of Purkinje Cell Degeneration
|
ACKERMAN, SUSAN
|
JACKSON LABORATORY
|
ME
|
$341,743
|
|
Huntington's Disease
|
NINDS
|
1R01NS056420-01A2
|
|
Huntington's Disease and Neurogenesis
|
ELLERBY, LISA
|
BUCK INSTITUTE FOR AGE RESEARCH
|
CA
|
$440,219
|
|
Huntington's Disease
|
NINDS
|
1R01NS055193-01A2
|
|
Mitochondrial Fission in Huntington's Disease
|
BOSSY-WETZEL, ELLA
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$309,506
|
|
Huntington's Disease
|
NINDS
|
5R01NS039324-09
|
|
Modulation of caspase pathways in Huntington's Disease
|
FRIEDLANDER, ROBERT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$395,953
|
|
Huntington's Disease
|
NINDS
|
5R01NS035663-09
|
|
Ascorbate as Extracellular Neuromodulator in Neostriatum
|
REBEC, GEORGE
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$186,049
|
|
Huntington's Disease
|
NINDS
|
5R01NS046579-05
|
|
Dendritic Ca signals in striatal medium spiny neurons
|
SABATINI, BERNARDO
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$334,491
|
|
Huntington's Disease
|
NINDS
|
5K23NS055733-02
|
|
Cognition in Clinical Trials for Huntington's Disease
|
BEGLINGER, LEIGH
|
UNIVERSITY OF IOWA
|
IA
|
$155,145
|
|
Huntington's Disease
|
NINDS
|
5R01NS052534-04
|
|
Induction of Striatal Regeneration in Huntington's Disease
|
GOLDMAN, STEVEN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$342,057
|
|
Huntington's Disease
|
NINDS
|
5R01NS052370-03
|
|
Dopamine modulation of the neostriatal feedback circuitry
|
KOOS, TIBOR
|
RUTGERS THE STATE UNIV OF NJ NEWARK
|
NJ
|
$303,790
|
|
Huntington's Disease
|
NINDS
|
5R01NS042892-05
|
|
Proteasomes, PODs and Polyglutamine Diseases
|
RECHSTEINER, MARTIN
|
UNIVERSITY OF UTAH
|
UT
|
$327,804
|
|
Huntington's Disease
|
NINDS
|
5R01NS052724-04
|
|
Estrogenic Regulation of Mitochondrial Transcription in Huntington's Disease
|
RYU, HOON
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$248,648
|
|
Huntington's Disease
|
NINDS
|
5R01NS052789-03
|
|
Pathogenic Impact of SUMO modification in Huntington's disease
|
THOMPSON, LESLIE
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$333,174
|
|
Huntington's Disease
|
NINDS
|
5R01NS056114-02
|
|
Atomistic Studies of Nucleation and Oligomerization in Polyglutamine Aggregation
|
PAPPU, ROHIT
|
WASHINGTON UNIVERSITY
|
MO
|
$284,302
|
|
Huntington's Disease
|
NINDS
|
5R01NS052619-03
|
|
Coordination and Statistics for CoQ10 in HD [2CARE]
|
MCDERMOTT, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$1,559,458
|
|
Huntington's Disease
|
NICHD
|
1F32HD057695-01
|
|
Category Learning in Dynamic Environments
|
HOFFMAN, AARON
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$48,739
|
|
Huntington's Disease
|
NINDS
|
5R21NS055942-02
|
|
Therapeutic Neuroprotective Trials of Tiagabine in HD Mouse Models
|
DUAN, WENZHEN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$215,250
|
|
Huntington's Disease
|
NINDS
|
1F31NS060523-01A1
|
|
The role of TrkB signaling in the survival and function of striatal neurons.
|
BAYDYUK, MARYNA
|
GEORGETOWN UNIVERSITY
|
DC
|
$29,294
|
|
Huntington's Disease
|
NHGRI
|
1F31HG004918-01
|
|
Instability of Triplet Repeats in Mammalian Cells
|
HUBERT, LEROY
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$40,972
|
|
Huntington's Disease
|
NINDS
|
5R01NS055247-02
|
|
Huntingtin interacting proteins as modifiers of Huntington's disease
|
HUGHES, ROBERT
|
BUCK INSTITUTE FOR AGE RESEARCH
|
CA
|
$424,375
|
|
Huntington's Disease
|
NINDS
|
5R01NS052597-03
|
|
Reconstruction of nigrostriatal pathway by photopolymerized neurotrophin...
|
BJUGSTAD, KIMBERLY
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$326,804
|
|
Huntington's Disease
|
NIMH
|
5R01MH080726-11
|
|
Molecular Studies of Human CNS Glutamate Transporters
|
AMARA, SUSAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$309,920
|
|
Huntington's Disease
|
NINDS
|
5F31NS059130-02
|
|
Mechanism of Fast Axonal Transport Inhibition by PolyQ-Expanded Huntingtin
|
POLLEMA, SARAH
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$51,810
|
|
Huntington's Disease
|
NINDS
|
5R01NS038106-09
|
|
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE
|
CHA, JANG-HO
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$345,345
|
|
Huntington's Disease
|
NINDS
|
5R21NS059647-02
|
|
Mice for development of HD therapeutics
|
DETLOFF, PETER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$158,594
|
|
Huntington's Disease
|
NINDS
|
5R01NS054893-02
|
|
Cognitive and functional brain changes in preclinical Huntington's disease (HD)
|
PAULSEN, JANE
|
UNIVERSITY OF IOWA
|
IA
|
$381,870
|
|
Huntington's Disease
|
NINDS
|
5R01NS050596-04
|
|
Roles of BDNF in Striatal Neurons and Relevance to Huntington's Disease
|
XU, BAOJI
|
GEORGETOWN UNIVERSITY
|
DC
|
$306,272
|
|
Huntington's Disease
|
NINDS
|
5R01NS049206-04
|
|
Huntington's Disease Repeat Instability and Pathogenesis
|
WHEELER, VANESSA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$367,272
|
|
Huntington's Disease
|
NINDS
|
5R01NS052203-04
|
|
Modeling Huntington's Disease in Drosophila
|
LITTLETON, J
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$344,754
|
|
Huntington's Disease
|
NINDS
|
5R01NS032765-13
|
|
Delineating the Huntington's disease mechanism by manipulating the mouse HD
|
MACDONALD, MARCY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$372,969
|
|
Huntington's Disease
|
NINDS
|
5R01NS049501-05
|
|
Conditional Mouse Models: Non-cell-antonomous Toxicities in Huntington's Disease
|
YANG, XIANGDONG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$338,768
|
|
Huntington's Disease
|
NINDS
|
1P01NS058793-01A1
|
0002
|
Biomarkers in Huntington's disease: Targeted and survey Metabolomics
|
MATSON, WAYNE
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$152,263
|
|
Huntington's Disease
|
NINDS
|
1P01NS058793-01A1
|
0003
|
Genomic markers of disease progression in Huntington's disease
|
SCHERZER, CLEMENS
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$281,120
|
|
Huntington's Disease
|
NINDS
|
1P01NS058793-01A1
|
9002
|
Clinical Core
|
HERSCH, STEVEN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$71,868
|
|
Huntington's Disease
|
NINDS
|
1P01NS058793-01A1
|
9003
|
Animal Core
|
FERRANTE, ROBERT
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$103,655
|
|
Huntington's Disease
|
NINDS
|
5R01NS041574-07
|
|
Pathophysiology of Transgenic Mouse Models of Huntington's Disease
|
LEVINE, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$303,188
|
|
Huntington's Disease
|
NINDS
|
5R01NS042625-07
|
|
Cell biology and dysfunction in polyglutamine diseases
|
PITTMAN, RANDALL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$344,531
|
|
Huntington's Disease
|
NINDS
|
1R21NS062216-01
|
|
Methods to reduce HD gene expression
|
DETLOFF, PETER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$190,313
|
|
Huntington's Disease
|
NINDS
|
5F31NS057866-02
|
|
Resurgent Na current: regulation and reconstitution in cultured neurons
|
AMAN, TERESA
|
NORTHWESTERN UNIVERSITY
|
IL
|
$27,648
|
|
Huntington's Disease
|
NINDS
|
5R01NS038194-09
|
|
Signaling Mechanisms in Neuronal Degeneration
|
ARONIN, NEIL
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$334,382
|
|
Huntington's Disease
|
NINDS
|
5R01NS050199-05
|
|
Protein Trafficking in Neurodegenerative Diseases
|
YAMAMOTO, AI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$353,020
|
|
Huntington's Disease
|
NINDS
|
5R01NS033538-13
|
|
Neurophysiological Modulation by Dopamine in the Neostriatum
|
LEVINE, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$301,870
|
|
Huntington's Disease
|
NIA
|
5R01AG026647-04
|
|
C. Elegans Model for Neurodegenerative Diseases of Aging
|
MORIMOTO, RICHARD
|
NORTHWESTERN UNIVERSITY
|
IL
|
$397,443
|
|
Huntington's Disease
|
NIDDK
|
1R15DK081191-01
|
|
Effect of G-rich Higher Order Structures on Insulin Linked Polymorphism Region
|
MAO, HANBIN
|
KENT STATE UNIVERSITY AT KENT
|
OH
|
$219,000
|
|
Huntington's Disease
|
NINDS
|
1R01NS059690-01A1
|
|
Molecular Chaperones and Small Molecules
|
GESTWICKI, JASON
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$287,557
|
|
Huntington's Disease
|
NINDS
|
1R01NS057715-01A2
|
|
The Role of Microglia and the Kynurenine Pathway in Huntington's Disease
|
MUCHOWSKI, PAUL
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$376,258
|
|
Huntington's Disease
|
NINDS
|
2R01NS037532-09A1
|
|
Somatosensory Cortical Influences on Subcortical Processing
|
ALLOWAY, KEVIN
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$300,923
|
|
Huntington's Disease
|
NINDS
|
5F31NS055516-03
|
|
Functional Microcircuitry of Corticostriatal Projections
|
MILLER, MARK
|
BRANDEIS UNIVERSITY
|
MA
|
$13,790
|
|
Huntington's Disease
|
NIA
|
2P01AG022074-06
|
0006
|
Mechanisms of Cell-specific Huntingtin-induced Neurodegeneration
|
FINKBEINER, STEVEN
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$391,552
|
|
Huntington's Disease
|
NIA
|
2P01AG022074-06
|
0007
|
Microglial Kynurenine Pathway and Selective Neuronal Vulnerability
|
MUCHOWSKI, PAUL
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$399,832
|
|
Huntington's Disease
|
NIA
|
5R01AG019322-08
|
|
Assembly and structures of polyglutamine aggregates
|
WETZEL, RONALD
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$254,588
|
|
Huntington's Disease
|
NINDS
|
1K23NS059743-01A1
|
|
Identification of Biomarkers of Huntington Disease in Human and Rat
|
BORDELON, YVETTE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$164,160
|
|
Huntington's Disease
|
NINDS
|
1R21NS057311-01A2
|
|
PSD-95 in Striatal Neuronal Vulnerability
|
YAO, WEI-DONG
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$227,719
|
|
Huntington's Disease
|
NINDS
|
1R01NS051303-01A2
|
|
Transcriptional Regulation of PGC-1 in Huntington's Disease
|
KRAINC, DIMITRI
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$351,333
|
|
Huntington's Disease
|
NINDS
|
1R03NS058376-01A1
|
|
Localization and Function of Huntingtin Associated protein 1 (Hap1) in C.elegans
|
GUTEKUNST, CLAIRE-ANNE
|
EMORY UNIVERSITY
|
GA
|
$80,651
|
|
Huntington's Disease
|
NINDS
|
5U01NS049077-05
|
|
Development of New Therapies for Huntington's Disease
|
BEAL, M
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$358,502
|
|
Huntington's Disease
|
NINDS
|
1R21NS061257-01A1
|
|
Conformation-specific Single-chain Antibodies as Neurodegeneration Research Tools
|
SIERKS, MICHAEL
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$176,394
|
|
Huntington's Disease
|
NIAAA
|
5R01AA010158-12
|
|
Hypothalamic-Pituitary-Adrenal Axis and Alcoholism
|
WAND, GARY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$520,635
|
|
Huntington's Disease
|
NINDS
|
5R01NS055298-02
|
|
Intrabodies For Huntington's Disease Therapy
|
PATTERSON, PAUL
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$365,989
|
|
Huntington's Disease
|
RMAP
|
5DP1OD000580-04
|
|
NIH Director's Pioneer Award
|
YUAN, JUNYING
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$827,584
|
|
Huntington's Disease
|
NINDS
|
7F32NS059237-02
|
|
Non-alledle specific RNAi as a potential therapy for Huntington's disease
|
MCBRIDE, JODI
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$49,646
|
|
Huntington's Disease
|
NINDS
|
5R21NS060205-02
|
|
Identification of Novel Biomarkers in HD
|
FOROUD, TATIANA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$198,844
|
|
Huntington's Disease
|
RMAP
|
5RL1NS062413-02
|
|
HDACs in Neurodegeneration and Aging
|
ELLERBY, LISA
|
BUCK INSTITUTE FOR AGE RESEARCH
|
CA
|
$436,500
|
|
Huntington's Disease
|
NCCAM
|
5U01AT000613-07
|
|
Creatine Safety, Tolerability, and Efficacy in Huntington's Disease: CREST-E
|
HERSCH, STEVEN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$1,964,317
|
|
Huntington's Disease
|
OD
|
5U01AT000613-07
|
|
Creatine Safety, Tolerability, and Efficacy in Huntington's Disease: CREST-E
|
HERSCH, STEVEN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$300,000
|
|
Huntington's Disease
|
NCCAM
|
5U01AT004526-02
|
|
Creatine Safety and Efficacy in HD: Coordination and Statistical Center
|
RAVINA, BERNARD
|
UNIVERSITY OF ROCHESTER
|
NY
|
$1,048,769
|
|
Huntington's Disease
|
NHGRI
|
5R01HG002449-07
|
|
Prospective Huntington At Risk Observational Study (PHAROS)
|
SHOULSON, IRA
|
UNIVERSITY OF ROCHESTER
|
NY
|
$519,286
|
|
Huntington's Disease
|
NINDS
|
5R01HG002449-07
|
|
Prospective Huntington At Risk Observational Study (PHAROS)
|
SHOULSON, IRA
|
UNIVERSITY OF ROCHESTER
|
NY
|
$250,000
|
|
Huntington's Disease
|
NIA
|
1R21AG032414-01
|
|
Suppression of the heat shock response in aging and neurodegeneration
|
SHERMAN, MICHAEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$243,750
|
|
Huntington's Disease
|
NINDS
|
5F31NS060218-02
|
|
Effects of estrogen on neuropathophysiology and behavior in Huntington's disease
|
DORNER, JENELLE
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$39,839
|
|
Huntington's Disease
|
NINDS
|
2R01NS040068-08
|
|
Neurobiological Predictors of Huntington's Disease
|
PAULSEN, JANE
|
UNIVERSITY OF IOWA
|
IA
|
$5,989,792
|
|
Huntington's Disease
|
NINDS
|
1R41NS063573-01
|
|
Developing Adjuvant SiRNA Therapy for Huntington's Disease
|
JIN, PENG
|
ERAGENE PHARMACEUTICALS, INC.
|
GA
|
$99,960
|
|
Huntington's Disease
|
NIEHS
|
1R01ES016931-01
|
|
Gene-environment interactions between manganese exposure and Huntington disease
|
BOWMAN, AARON
|
VANDERBILT UNIVERSITY
|
TN
|
$543,594
|
|
Huntington's Disease
|
NINDS
|
5P01NS050210-04
|
0001
|
RNAi for Huntington's Disease
|
DAVIDSON, BEVERLY
|
UNIVERSITY OF IOWA
|
IA
|
$308,639
|
|
Huntington's Disease
|
NINDS
|
1R21NS061998-01A1
|
|
Cell Cycle Control of Trinucleotide Instability in Mammalian Cells
|
KOVTUN, IRINA
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$165,266
|
|
Huntington's Disease
|
NINDS
|
1R01NS059921-01A1
|
|
Basal Ganglia Functions in Huntington's Disease: Genetic Mouse Models
|
ABERCROMBIE, ELIZABETH
|
RUTGERS THE STATE UNIV OF NJ NEWARK
|
NJ
|
$337,969
|
|
Huntington's Disease
|
NINDS
|
1R21NS059537-01A2
|
|
Neurodegeneration in Aging Retarded Mice
|
ALBIN, ROGER
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$158,904
|
|
Huntington's Disease
|
NINDS
|
3R01NS015841-30S1
|
|
Electroanalysis of Neurotransmitters and Modulators
|
WIGHTMAN, ROBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$42,277
|
|
Huntington's Disease
|
NINDS
|
7R01NS038712-10
|
|
Mechanisms of Polyglutamine Neurodegeneration
|
PAULSON, HENRY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$202,450
|
|
Huntington's Disease
|
NINDS
|
5P50NS016367-28
|
0014
|
Genetic Studies of Huntington's Disease
|
MYERS, RICHARD
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$267,987
|
|
Huntington's Disease
|
NINDS
|
5P50NS016367-28
|
0015
|
Genetic and Chemical Modifiers in HD
|
GUSELLA, JAMES
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$344,433
|
|
Huntington's Disease
|
NINDS
|
5P50NS016367-28
|
0016
|
Modifiers of Steps in HD Pathogenesis
|
MACDONALD, MARCY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$446,224
|
|
Huntington's Disease
|
NIA
|
5P01AG014930-08
|
0001
|
TRANSCRIPTIONAL RESPONSES TO MITOCHONDRIAL DYSFUNCTION
|
RATAN, RAJIV
|
WINIFRED MASTERSON BURKE MED RES INST
|
NY
|
$1,360,888
|
|
Huntington's Disease
|
NINDS
|
3R01NS053912-03S1
|
|
Intrabodies as novel neurological therapeutics
|
MESSER, ANNE
|
WADSWORTH CENTER
|
NY
|
$33,478
|
|
Huntington's Disease
|
OD
|
2R56MH066128-06
|
|
Synaptic processing in the basal ganglia
|
PERKEL, DAVID
|
UNIVERSITY OF WASHINGTON
|
WA
|
$392,805
|
|
Huntington's Disease
|
OD
|
2R56NS028721-15
|
|
Neuropathology and Pathogenesis of Huntington's Disease
|
REINER, ANTON
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$321,927
|
|
Huntington's Disease
|
NIBIB
|
5P41EB002030-13
|
0002
|
PROJECT 2; CHEMICAL SAMPLING AND ANALYSIS OF BRAIN EXTRACELLULAR FLUID
|
KENNEDY, ROBERT
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$140,808
|
|
Huntington's Disease
|
NINDS
|
3R01NS053912-03S2
|
|
Intrabodies as novel neurological therapeutics
|
MESSER, ANNE
|
WADSWORTH CENTER
|
NY
|
$77,841
|
|
Huntington's Disease
|
NIA
|
5P01AG027916-03
|
0003
|
THE BIOLOGY AND UTILITY OF SIRT1- MEDIATED NEUROPROTECTION
|
SINCLAIR, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$289,606
|
|
Huntington's Disease
|
NIA
|
5P01AG027916-03
|
0004
|
AUTOPHAGY, DNA DAMAGE AND ONSET OF HUNTINGTON'S DISEASE.
|
YUAN, JUNYING
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$315,317
|
|
Huntington's Disease
|
NINDS
|
5P50NS016375-28
|
0016
|
Clinical progression and pathologic correlates of Huntington's disease
|
ROSENBLATT, ADAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$221,598
|
|
Huntington's Disease
|
NINDS
|
5P50NS016375-28
|
0017
|
Clinical progression and pathologic correlates of Huntington's disease
|
ROSS, CHRISTOPHER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$93,726
|
|
Huntington's Disease
|
NINDS
|
5P50NS016375-28
|
0018
|
Clinical progression and pathologic correlates of Huntington's disease
|
READING, SARAH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$560,960
|
|
Huntington's Disease
|
NINDS
|
5P50NS016375-28
|
9001
|
Clinical Core
|
IRANI, DAVID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$199,954
|
|
Huntington's Disease
|
NINDS
|
5P50NS016375-28
|
9002
|
nueropathy core
|
TRONCOSO, JUAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$105,660
|
|
Huntington's Disease
|
NINDS
|
2R56NS043466-06A1
|
|
Loss-of-function mechanisms in Huntington's disease
|
ZEITLIN, SCOTT
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$340,875
|
|
Huntington's Disease
|
NINDS
|
5U54NS039408-09
|
0004
|
Mitochondrial DNA damage and repair in neurodegeneration
|
AYALA-TORRES, SYLVETTE
|
UNIVERSIDAD CENTRAL DEL CARIBE
|
PR
|
$421,198
|
|
Huntington's Disease
|
NIAAA
|
3R01AA010158-12S1
|
|
Hypothalamic-Pituitary-Adrenal Axis and Alcoholism
|
WAND, GARY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$135,000
|
|
Huntington's Disease
|
NCRR
|
2P51RR000168-47
|
5584
|
NOVEL THERAPEUTIC APPROACHES FOR HUNTINGTON?S DISEASE
|
ISACSON, OLE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$55,151
|
|
Huntington's Disease
|
NCRR
|
5P51RR000165-48
|
5891
|
A TRANSGENIC MONKEY: INHERITED NEURODEGENERATIVE DISEASES
|
CHAN, ANTHONY WING SANG
|
EMORY UNIVERSITY
|
GA
|
$35,600
|
|
Huntington's Disease
|
NCRR
|
5M01RR000750-36
|
7586
|
PILOT HUNTINGTON AT RISK OBSERVATIONAL STUDY (PHAROS)
|
QUAID, KIMBERLY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$378
|
|
Huntington's Disease
|
NCRR
|
5M01RR000750-36
|
7596
|
LONGITUDINAL STUDIES AMONG AT-RISK HD GENE CARRIERS
|
FOROUD, TATIANA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$887
|
|
Huntington's Disease
|
NCRR
|
5M01RR000750-36
|
7599
|
NEUROLOGICAL PREDICTORS OF HUNTINGTON DISEASE (PREDICT-HD)
|
QUAID, KIMBERLY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$276
|
|
Huntington's Disease
|
NCRR
|
5M01RR000750-36
|
7691
|
COOPERATIVE HUNTINGTON'S OBSERVATIONAL RESEARCH TRIAL (COHORT)
|
QUAID, KIMBERLY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$102
|
|
Huntington's Disease
|
NCRR
|
5M01RR007122-17
|
8322
|
CLINICAL TRIAL: PILOT HUNTINGTON AT RISK OBSERVATIONAL STUDY (PHAROS)
|
CARESS, JAMES
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$20,645
|
|
Huntington's Disease
|
NCRR
|
5M01RR007122-17
|
8353
|
COOPERATIVE HUNTINGTON'S DISEASE OBSERVATIONAL RESEARCH TRIAL
|
WALKER, FRANCIS
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$18,065
|
|
Huntington's Disease
|
NCRR
|
5M01RR023940-02
|
8454
|
PHAROS
|
DUBINSKY, RICHARD
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$7,334
|
|
Huntington's Disease
|
NCRR
|
5M01RR023940-02
|
8468
|
COHORT
|
DUBINSKY, RICHARD
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$46,929
|
|
Huntington's Disease
|
NCRR
|
2M01RR018535-06
|
5502
|
BRAIN NETWORKS AS FUNCTIONAL BIOMARKERS OF PRECLINICAL HUNTINGTON'S DISEASE
|
TANG, CHAI-MEI
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$21,179
|
|
Huntington's Disease
|
NCRR
|
5P20RR020171-05
|
7028
|
STUDIES OF RILP AND RILP-BINDING PROTEIN DYNACTIN P150GLUED AND HUNTINGTIN
|
SHIMOJO, MASAHITO
|
UNIVERSITY OF KENTUCKY
|
KY
|
$249,094
|
|
Huntington's Disease
|
NCRR
|
5P41RR002250-23
|
7286
|
HUNTINGTIN
|
FRYDMAN, JUDITH
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$16,231
|
|
Huntington's Disease
|
NCRR
|
2P41RR008079-16
|
7492
|
NEUROCHEMICAL PROFILES OF RODENTS MEASURED AT 94 T
|
RAO, RADHAKRISHNA
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$17,835
|
|
Huntington's Disease
|
NCRR
|
5P41RR001209-29
|
7849
|
STRUCTURAL STUDIES ON PROTEINS THAT CONTROL APOPTOSIS, SULFUR ASSIMILATION & NEU
|
FISHER, ANDREW
|
STANFORD UNIVERSITY
|
CA
|
$4,399
|
|
Huntington's Disease
|
NCRR
|
5P41RR001209-29
|
7892
|
STRUCTURES OF PROSTATE SPECIFIC MEMBRANE ANTIGEN, PIGR, A GE/GI-FC AND AN ANTI-P
|
BJORKMAN, PAMELA
|
STANFORD UNIVERSITY
|
CA
|
$757
|
|
Huntington's Disease
|
NCRR
|
5P41RR001209-29
|
8153
|
WHAT IS THE STRUCTURAL CORRELATE OF INTRACELLULAR POLYGLUTAMINE TOXICITY?
|
PETERS-LIBEU, CLARE
|
STANFORD UNIVERSITY
|
CA
|
$757
|
|
Huntington's Disease
|
NCRR
|
5P41RR004050-20
|
8503
|
STRIATAL NEUROANATOMY IN DOPAMINE TRANSPORTER KNOCKOUT MICE
|
CARON, MARC
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$35,121
|
|
Huntington's Disease
|
NCRR
|
5P41RR004050-20
|
8551
|
HUNTINGTIN MICROAGGREGATES AND CELL TOXICITY: LIVE CELL IMAGING
|
ROSS, CHRISTOPHER
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$9,756
|
|
Huntington's Disease
|
NCRR
|
5P41RR010888-12
|
5255
|
CHARACTERIZATION OF POLYGLUTAMINE AGGREGATES BY MASS SPECTROMETRY
|
SHERMAN, MICHAEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$44,071
|
|
Huntington's Disease
|
NCRR
|
5P41RR010888-12
|
5297
|
LC/EC-LC/MS STUDIES OF PROTEIN AND OXIDIZED NEUROTRANSMITTER INTERACTIONS
|
MATSON, WAYNE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$12,961
|
|
Huntington's Disease
|
NCRR
|
5P41RR006009-18
|
5443
|
STUDY OF TRINUCLEOTIDE REPEAT SEQUENCES USING THE GENERALIZED BORN MODEL
|
BOMBLE, YANNICK
|
CARNEGIE-MELLON UNIVERSITY
|
PA
|
$473
|
|
Huntington's Disease
|
NCRR
|
5P41RR003155-23
|
6262
|
HUNTINGTON PROTEIN AGGREGATION IN PC12 CELLS
|
BARCELLONA, MARISA
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$8,848
|
|
Huntington's Disease
|
NCRR
|
5P41RR013642-11
|
6628
|
HUNTINGTON'S DISEASE NEUROIMAGING INITIATIVE
|
CASH, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$2,576
|
|
Huntington's Disease
|
NCRR
|
5P41RR013642-11
|
6645
|
HUNTINGTON'S DISEASE
|
ASADI, AMRAN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$5,153
|
|
Huntington's Disease
|
NCRR
|
5M01RR000827-33
|
7006
|
HUMAN PSYCHOPHYSIOLOGICAL CORRELATES OF SENSORIMOTOR FUNCTIONING
|
SWERDLOW, NEAL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$21,065
|
|
Huntington's Disease
|
NCRR
|
5M01RR000827-33
|
7048
|
CLINICAL TRIAL: TRIAL OF ETHYL-EPA IN SUBJECTS WITH MILD TO MODERATE HUNTINGTON'
|
COREY-BLOOM, JODY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$457
|
|
Huntington's Disease
|
NCRR
|
5M01RR000827-33
|
7058
|
CLINICAL TRIAL: A MULTICENTER PHASE 1-2A STUDY OF DIMEBON IN SUBJECTS WITH HUNTI
|
COREY-BLOOM, JODY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$44,421
|
|
Huntington's Disease
|
NCRR
|
5M01RR000827-33
|
7070
|
CLINICAL TRIAL: COOPERATIVE HUNTINGTON'S OBSERVATIONAL TRIAL (COHORT)
|
COREY-BLOOM, JODY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$8,243
|
|
Huntington's Disease
|
NCRR
|
2P41RR005959-19
|
7753
|
CHARACTERIZATION OF NEURAL NETWORK ALTERATIONS IN HUNTINGTON'S DISEASE MODEL
|
LEERGAARD, TRYGVE
|
DUKE UNIVERSITY
|
NC
|
$12,945
|
|
Huntington's Disease
|
NCRR
|
2M01RR001066-31
|
8222
|
CLINICAL TRIAL: CREST-X
|
ROSAS, HERMINIA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$2,752
|
|
Huntington's Disease
|
NIA
|
1Z01AG000329-01
|
|
Exercise and brain function in a mouse model of Huntington's Disease.
|
VAN PRAAG, HENRIETTE
|
NIH
|
|
$174,706
|
|
Huntington's Disease
|
NIMH
|
1Z01MH002468-21
|
|
Mechanisms Of Action Of Psychoactive Drugs
|
CHUANG, DE-MAW
|
NIH
|
|
$1,863,362
|
